BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15032565)

  • 21. Monitoring anticoagulation in atrial fibrillation.
    Sarawate C; Sikirica MV; Willey VJ; Bullano MF; Hauch O
    J Thromb Thrombolysis; 2006 Apr; 21(2):191-8. PubMed ID: 16622617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study.
    Mittal VS; Wu B; Song J; Milentijevic D; Ashton V; Mahajan D
    Curr Med Res Opin; 2020 Apr; 36(4):529-536. PubMed ID: 31858841
    [No Abstract]   [Full Text] [Related]  

  • 23. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation.
    Yaghi S; Liberman AL; Henninger N; Grory BM; Nouh A; Scher E; Giles J; Liu A; Nagy M; Kaushal A; Azher I; Fakhri H; Espaillat KB; Asad SD; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Trivedi T; Ishida K; Frontera J; Lord A; Furie K; Keyrouz S; de Havenon A; Mistry E; Leon Guerrero CR; Khan M
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104888. PubMed ID: 32414583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic.
    Griffin BL; Burkiewicz JS; Peppers LR; Warholak TL
    Am J Health Syst Pharm; 2009 Jul; 66(13):1218-23. PubMed ID: 19535661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
    Dager WE; Branch JM; King JH; White RH; Quan RS; Musallam NA; Albertson TE
    Ann Pharmacother; 2000 May; 34(5):567-72. PubMed ID: 10852081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT).
    Smith DE; Xuereb CB; Pattison HM; Lip GY; Lane DA
    BMC Cardiovasc Disord; 2010 May; 10():21. PubMed ID: 20487528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
    Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
    [No Abstract]   [Full Text] [Related]  

  • 30. Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance.
    Bobade RA; Helmers RA; Jaeger TM; Odell LJ; Haas DA; Kaplan RS
    J Med Econ; 2019 May; 22(5):471-477. PubMed ID: 30744455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients.
    Lackner TE; Battis GN
    Arch Fam Med; 1995 Dec; 4(12):1017-26. PubMed ID: 7496550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA
    Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
    JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling patients' time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants.
    Leminen A; Pyykönen M; Tynkkynen J; Tykkyläinen M; Laatikainen T
    BMC Health Serv Res; 2019 Nov; 19(1):901. PubMed ID: 31775847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
    Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
    Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population.
    Deitelzweig SB; Buysman E; Pinsky B; Lacey M; Jing Y; Wiederkehr D; Graham J
    Clin Ther; 2013 Aug; 35(8):1201-10. PubMed ID: 23867114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.